NASDAQ:ADTX
ADiTx Therapeutics, Inc. Stock News
$2.07
+0 (+0%)
At Close: May 10, 2024
Aditxt Secures $5 Million Financing to Scale AditxtScore™ Operational Capacity
08:54am, Tuesday, 26'th Jan 2021
Balance Sheet Further Strengthened by Receipt of Additional $3.3 Million from Exercise of Existing Warrants
Why ADiTx Shares Are Rallying To A 5-Month High
12:11pm, Thursday, 21'st Jan 2021
Shares of ADiTx Therapeutics Inc (NASDAQ: ADTX) are trading at a five-month high Thursday after ADiTx announced it would launch the AditxtScore Immune Monitoring Platform on Feb. 1. The initial applic
30 Year Industry Veteran with FDA and EMA Experience will Assume Newly Created Executive RoleLoma Linda, CA, Aug. 14, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Aditx Therapeutics, Inc. (Aditxt) (th
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.17%
12:00am, Friday, 07'th Aug 2020
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.17%
Aditxt Introduces AditxtScore™ for COVID-19 and Announces the Completion of Validation Studies by Stanford Blood Center
12:00pm, Thursday, 06'th Aug 2020
Company Plans to file for an Emergency Use Authorization (EUA) and 510(k) Application in the Current Quarter (Q3, 2020)Loma Linda, CA, Aug. 06, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Aditxt Ther
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.68%
12:00am, Thursday, 06'th Aug 2020
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.68%
LOMA LINDA, CA, Aug. 03, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Aditx Therapeutics, Inc. (Aditxt) (the “Company”) (Nasdaq: ADTX), a life sciences company developing technologies specificall
Ms. Anthony and Her Legal Team have Represented Private and Public Finance Transactions in excess of $1 BillionLoma Linda, CA, July 24, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Aditx Therapeutics,
Aditxt to Present at Zooming with LD
12:00pm, Wednesday, 22'nd Jul 2020
Presentation on Tuesday, July 28th at 11:00 AM ETLoma Linda, CA, July 22, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Aditx Therapeutics, Inc. (Aditx) (the “Company”) (Nasdaq: ADTX), a life scien
Ms. Pankovcin has 30 Years of Public Company Financial Experience with World Class Organizations LOMA LINDA, Calif., July 21, 2020 -- via NEWMEDIAWIRE -- Aditx Therapeutics,.
'Zooming with LD' to Feature 10 Distinct Companies July 20th-31st
03:00pm, Thursday, 16'th Jul 2020
LOS ANGELES, CA / ACCESSWIRE / July 16, 2020 / LD Micro today announced that it will be hosting ten companies over the final two weeks of July, with a group presentation in the morning, followed by pr
CEO, CIO, and Senior Advisors of Aditxt Complete Conversion of ~$1.1 Million in Accrued Compensation into Restricted IPO Units
12:00pm, Friday, 10'th Jul 2020
Loma Linda, CA, July 10, 2020 -- via NEWMEDIAWIRE -- Aditx Therapeutics, Inc. (Aditxt) (the “Company”) (Nasdaq: ADTX), a life sciences company developing technologies.
CORRECTION: Aditx Therapeutics, Inc. (Aditxt) Announces Closing of Initial Public Offering
08:46pm, Monday, 06'th Jul 2020
The number of Series A warrants and Series B warrants purchased by the underwriters in the over-allotment option has been corrected to 128,328. Loma Linda, CA, July 06, 2020 (GLOBE NEWSWIRE) -- via
Aditx Therapeutics, Inc. (Aditxt) Announces Closing of Initial Public Offering
08:10pm, Thursday, 02'nd Jul 2020
Loma Linda, CA, July 02, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Aditx Therapeutics, Inc. (Aditxt) (the “Company”) (ADTX), a life sciences company developing technologies specifically focus
Aditx Therapeutics, Inc. (Aditxt) Announces Pricing of Initial Public Offering
01:49pm, Tuesday, 30'th Jun 2020
Loma Linda, CA, June 30, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Aditx Therapeutics, Inc. (the “Company”) (ADTX), a life sciences company developing technologies specifically focused on imp